Introduction
============

Hepatocellular carcinoma accounts for 90% of all primary liver malignancies ([@B33]; [@B17]), posing a serious threat to human health and quality of life. Worldwide, most patients with HCC have underlying cirrhosis of various etiologies ([@B16]; [@B5]; [@B47]). Growing clinical evidence shows that removal or control of the injurious factors, such as hepatitis B or C virus, can reduce but not eliminate the risk of HCC ([@B8]; [@B31]; [@B53]; [@B42]). Therefore, it is important to understand the molecular mechanisms that drive the progression of cirrhosis to HCC.

Hepatocellular carcinoma occurs as a consequence of the complex interplay between multiple genetic determinants ([@B38]). Previous studies have found that aberrations in genetic molecules pertaining to oxidative stress, EMT, inflammatory response, cellular senescence, or telomere dysfunction may contribute to the progression of cirrhosis to HCC ([@B36]). In addition, the Wnt/β-catenin, p53, pRb, MAPK, RAS, and JAK/STAT pathways are also reported to be canonical molecular pathways in HCC development ([@B2]). However, different studies often yield diverse results and the global view on the landscape of genomic changes is still not very clear.

With the aid of high-throughput detection techniques, all expressed genetic molecules in a given liver tissue sample can be simultaneously detected over a wide quantitative range ([@B32]; [@B45]; [@B56]; [@B51]; [@B21]; [@B39]; [@B46]; [@B14]; [@B41]). High-throughput sequencing and microarray technologies allow investigators to simultaneously measure the changes of genome-wide genes under certain biological conditions. These approaches usually generate large "interesting" gene lists. By using biological knowledge accumulated in public databases (e.g., KEGG^[1](#fn01){ref-type="fn"}^), it is possible to systematically dissect large gene lists in an attempt to assemble a summary of the most enriched and pertinent biology. Therefore, integrated analyses of multiple datasets generated from different studies may help us to identify reliable and reproducible genetic alterations involved in the development of HCC on a cirrhotic background.

Therefore, our present study used multiple bioinformatics tools to systematically integrate publicly available transcriptomic datasets and performed high-throughput gene expression comparisons between HCC and benign cirrhotic tissues.

Materials and Methods {#s1}
=====================

Retrieval of Microarray Datasets on Cirrhosis and HCC From Public Database
--------------------------------------------------------------------------

First, we searched and retrieved transcriptome profiles of cirrhotic and HCC tissues from GEO which is a public functional genomics data repository, allowing users to query, locate, review, and download studies and gene expression profiles of interest ([@B4]).

The search terms we used included "cirrhosis" and "HCC." Studies were considered eligible for analysis if: (1) studies contained both cirrhosis and HCC tissues; (2) species was limited to Homo sapiens; and (3) platform was limited to microarray. Then the retrieved datasets were further screened by manual retrieval. Our workflow for bioinformatics analysis of publicly available datasets is illustrated in [Figure 1](#F1){ref-type="fig"}.

![Workflow for bioinformatics analysis. GEO, Gene Expression Omnibus; HCC, hepatocellular carcinoma; STRING, Search Tool for the Retrieval of Interacting Genes; MCODE, Molecular Complex Detection; HCL, hierarchical clustering; PCA, principal component analysis; KEGG, Kyoto Encyclopedia of Genes and Genomes; HPA, Human Protein Atlas. ROC, receiver operating characteristic.](fgene-10-00305-g001){#F1}

Identification of DEGs Related to Liver Carcinogenesis From the Retrieved Microarray Datasets
---------------------------------------------------------------------------------------------

Differentially expressed genes between cirrhosis and HCC tissues were defined as liver carcinogenesis-related genes that may have important implications in driving cirrhosis to HCC.

Gene expression in all the datasets was normalized by the antilog-transformed RMA algorithm. GEO query and limma R packages contained in GEO2R, which allows gene expression analysis of published microarray datasets, was used to determine the DEGs between cirrhosis and HCC tissues ([@B12]). FDR \< 0.05 and FC \> 1.5 were considered as the cutoff values for DEG screening. The overlapping DEGs in datasets were retained for further analyses.

Functional Specification of the Identified DEGs Related to Liver Carcinogenesis
-------------------------------------------------------------------------------

To identify and visualize enriched KEGG pathways for the candidate gene sets, clusterProfiler, which is an R package for comparing biological themes among gene clusters, was employed ([@B57]). Fisher's exact test followed by the Benjamini correction was performed and an adjusted *P*-value of \<0.05 was set as the cutoff criterion.

Establishment of the LiverCarcinogenesis-Related Network andIts Modules
-----------------------------------------------------------------------

The internal regulatory relationships between the identified liver carcinogenesis-related genes were predicted by the STRING database (confidence score \> 0.4) ([@B43]). Liver carcinogenesis-related network was established and visualized with Cytoscape software ([@B40]).

We used the MCODE plug-in in the Cytoscape software ([@B3]) to screen the modules concealed in the liver carcinogenesis-related network with the following criteria: Max. depth = 100, K-Core = 2, mode score cutoff = 0.2, and degree cutoff = 2. Likewise, the functional specification of the identified module was determined with the clusterProfiler package as mentioned above. An adjusted *P*-value of \<0.05 was considered statistically significant.

Verification of the Identified Modules for Discriminating Cirrhosis From HCC
----------------------------------------------------------------------------

We used three of datasets (GSE89377, GSE17548, and GSE98383) to mine modules from the liver carcinogenesis-related network; and used the remaining dataset (GSE56140) to validate the findings. To verify the ability of the identified modules to discriminate cirrhosis from HCC subjects, we performed hierarchical clustering analysis by using R with the complete linkage method and the expression of modular genes as a distance metric. To verify the results of hierarchical clustering, we applied the identified modular genes that were considered as observed variables to PCA plots. PCA was conducted with the ggbiplot package in R. The first two principal components (PCs) were then subjected to binary logistic regression analysis to calculate the predicted probability which was applied to the receiver operating characteristic (ROC) curve analysis implemented by SPSS 20 (IBM, United States). Area under curve (AUC) was calculated to determine the predictive performance of the identified gene module. In order to reduce sampling bias, the modules were screened from any three out of the four datasets and repeated evaluations of their discriminant ability were performed using the remaining dataset.

Comparison of the Identified Modular Genes in Normal and Cirrhotic Samples
--------------------------------------------------------------------------

We used GEO2R software to determine the expression differences between any two groups in dataset. An FDR of \<0.05 and an FC of \>1.5 were considered as the cutoff values for DEG screening. Modular gene expression in normal, cirrhotic, and HCC samples were visualized by using a heatmap drawn with MeV software^[2](#fn02){ref-type="fn"}^.

Analyses of the Association Between the Top Modular Genes and HCC Histological Grade or Clinical Outcome
--------------------------------------------------------------------------------------------------------

Modular genes with FC \> 3 between cirrhosis and HCC tissues in all GEO datasets were considered as the top modular genes. Association of the top modular genes and HCC grades or prognosis was analyzed by using UALCAN ([@B9]), which is an interactive web-portal for exploring the association between tumor subgroup gene expression and survival in TCGA^[3](#fn03){ref-type="fn"}^. Expression differences of top modular genes between normal and different tumor grades were analyzed using the statistical method built-in the UALCAN web-software; a *P*-value of \<0.05 was considered significant.

According to the TPM expression values, the top modular genes were divided into a high expression group (with TPM values above upper quartile) and a low expression group (with TPM values below lower quartile). With information on the association between the gene expression and survival profiles documented in TCGA, Kaplan--Meier survival analyses were performed and overall survival plots were generated. The difference between high gene expression and low gene expression was compared by log-rank test; a *P*-value of \< 0.05 was considered significant.

*In silico* Analysis of the Top Modular Members in Normal and HCC Specimens
---------------------------------------------------------------------------

Protein expression and distribution of the top modular genes in human liver tissue were searched in the HPA ^[4](#fn04){ref-type="fn"}^ database ([@B44]).

Results
=======

Retrieved Microarray Datasets Pertaining to Cirrhosis and HCC
-------------------------------------------------------------

According to the retrieval criteria, four microarray datasets ([Table 1](#T1){ref-type="table"}) containing a total of 95 benign (cirrhosis) and 98 malignant (HCC) subjects were found from the GEO database. GSE98983 dataset was produced by Affymetrix Human Genome U133 Plus 2.0 Array (GPL570); GSE89377 by Illumina HumanHT-12 V3.0 expression beadchip (GPL6947); GSE17548 by Affymetrix Human Genome U133 Plus 2.0 Array (GPL570); and.GSE56140 by Illumina HumanHT-12 V3.0 expression beadchip.

###### 

Detailed information of the four microarray datasets used in the present study.

  ID         Platform   Sample              Etiology                    References
  ---------- ---------- ------------------- --------------------------- ------------
  GSE98383   GPL570     LC = 29; HCC = 11   HDV                         [@B14]
  GSE89377   GPL6947    LC = 12; HCC = 35   HBV, HCV, alcohol, others   [@B41]
  GSE17548   GPL570     LC = 20; HCC = 17   HBV, HCV, HBV+HDV, others   [@B56]
  GSE56140   GPL18461   LC = 34; HCC = 35   HBV, HCV                    [@B45]

LC, liver cirrhosis; HCC, hepatocellular carcinoma; HBV, hepatic B virus; HCV, hepatic C virus; HDV, hepatic D virus.

DEGs Related to Liver Carcinogenesis
------------------------------------

In total, we found 125 upregulated and 252 downregulated genes (adjusted *P* \< 0.05 and FC \> 1.5) in HCC tissues when compared with cirrhosis tissues. These DEGs were shared by the three independent datasets (GSE98383, GSE89377, and GSE17548) ([Figure 2A,B](#F2){ref-type="fig"} and [Supplementary Table S1](#SM7){ref-type="supplementary-material"}).

![DEGs shared in three independent microarray datasets and their potential functions. A total of 125 upregulated genes **(A)** and 252 downregulated genes **(B)** were shared between the GSE98383, GSE89377, and GSE17548 datasets when comparing HCC to cirrhosis subjects. Red indicates upregulation and blue represents downregulation. DEGs were determined using GEO2R software. FDR \< 0.05 and FC \> 1.5 were considered as the cutoff values. **(C)** Significantly enriched KEGG pathways of the total shared DEGs. ClusterProfiler package was selected to perform KEGG pathway enrichment analysis. Adjusted *P*-values of \<0.05 were considered statistically significant.](fgene-10-00305-g002){#F2}

Functional Specification of DEGs Related to Liver Carcinogenesis
----------------------------------------------------------------

Functional enrichment analysis revealed that these DEGs were significantly enriched in several KEGG pathways; as shown in [Figure 2C](#F2){ref-type="fig"}, the top ones were "cell cycle," "drug metabolism-cytochrome P450," "chemical carcinogenesis," "metabolism of xenobiotics by cytochrome P450," "retional metabolism," "DNA replication," "complement and coagulation cascades," "p53 signaling pathway," etc. Detailed information of these pathways is listed in [Supplementary Table S2](#SM8){ref-type="supplementary-material"}.

Network-Based Modules Involved in Liver Carcinogenesis
------------------------------------------------------

By screen against the STRING database, totally 2954 interactions were found among 272 DEGs, which was visualized by using Cytoscape software. The network layout was arranged with the Allegro Spring-Electric plug-in in Cytoscape software. As shown in [Figure 3A](#F3){ref-type="fig"}, the upregulated genes in the liver carcinogenesis-related network were highly connected, suggesting a core role in the whole network.

![The liver carcinogenesis-related module and its biological functions. **(A)** Liver carcinogenesis-related network. The internal interactions between DEG pairs were mined using STRING database and the network was visualized using Cytoscape software. Red nodes signify upregulated genes and blue nodes indicate downregulated genes. The edges between any two nodes represent internal interactions. **(B)** Liver carcinogenesis-related module. Members in this module are highly connected. All the modular genes were upregulated in HCC tissues. **(C)** Significantly enriched KEGG pathways of the modular genes. ClusterProfiler package was selected to perform functional specification. Adjusted *P*-values of \<0.05 were considered statistically significant.](fgene-10-00305-g003){#F3}

Then we used the MCODE plug-in to mine the highly clustered modules from this network. As expected, a module holding a higher connectivity (cluster score = 64.1) was identified, with 65 nodes and 1955 edges. Interestingly, all the modular genes were notably upregulated in HCC tissues compared with cirrhotic tissues, signifying their roles in liver carcinogenesis ([Figure 3B](#F3){ref-type="fig"} and [Supplementary Table S3](#SM9){ref-type="supplementary-material"}). These modular genes were involved in several KEGG pathways including "cell cycle," "DNA replication," "oocyte meiosis," "human T-cell leukemia virus 1 infection," "progesterone-mediated oocyte maturation," "cellular senescence," "p53 signaling pathway," "base excision repair," and "mismatch repair" ([Figure 3C](#F3){ref-type="fig"} and [Supplementary Table S4](#SM10){ref-type="supplementary-material"}).

Modular Gene Signatures Discriminating Cirrhosis From HCC
---------------------------------------------------------

Hierarchical clustering analysis of the validation dataset (GSE56140, 34 cirrhosis subjects and 35 HCC subjects) showed that subjects with the same diagnosis were inclined to be evidently more clustered ([Figure 4A](#F4){ref-type="fig"}). In agreement with the result of hierarchical clustering, as shown in [Figure 4B](#F4){ref-type="fig"}, the PCA plot clearly distinguished cirrhosis from HCC with a small overlap. The first two PCs that were the most informative, accounting for approximately 86.6 and 3.5% of the total observed variances, respectively. ROC analysis revealed an AUC of 0.919, indicating the identified modular genes, to some extent, could be a combined predictor of cirrhosis to HCC development ([Figure 4C](#F4){ref-type="fig"}).

![Verification of the identified modules for discriminating cirrhosis from HCC. **(A)** Hierarchical clustering dendrogram of all the subjects in GSE56140 (distance metric: modular gene expressions, linkage method: complete). Red represents HCC subjects and blue represents cirrhosis subjects. **(B)** PCA plot of all the subjects in GSE56140. HCC subjects are labeled in red and cirrhosis subjects are labeled in blue. The ellipse shows 95% confidence intervals. **(C)** The first two PCs were subjected to binary logistic regression analysis to calculate the predicted probability which was applied to the ROC analysis. AUC, area under curve.](fgene-10-00305-g004){#F4}

We next used any three out of the four datasets as training datasets to mine liver carcinogenesis-related modules. As shown in [Supplementary Figures S1](#SM1){ref-type="supplementary-material"}--[S3](#SM3){ref-type="supplementary-material"}, all the identified modules, as the module screened from GSE98383, GSE89377, and GSE17548, were characterized by upregulated genes and high connectivity; members in these modules identified from different training datasets were largely overlapped. In addition, hierarchical clustering, PCA and ROC analyses, to a large extent, could distinguish cirrhotic subjects from HCC subjects ([Supplementary Figures S4](#SM4){ref-type="supplementary-material"}--[S6](#SM6){ref-type="supplementary-material"}). These results indicated that the identified liver carcinogenesis-related module was not by chance and the ability of discriminating cirrhosis from HCC was relatively robust.

Characterization of the Modular Gene Expression Patterns in Normal, Cirrhotic, and HCC Livers
---------------------------------------------------------------------------------------------

The GSE89377 dataset contained not only cirrhosis (*n* = 12) and HCC (*n* = 35) subjects but also normal (*n* = 13) subjects. Therefore, we used this dataset to analyze the modular gene expression pattern in normal, cirrhotic, and HCC livers. As shown in [Figure 5](#F5){ref-type="fig"}, while the modular genes being differentially expressed between HCC and cirrhosis/normal livers (adjusted *P* \< 0.05 and FC \> 1.5), there were no significant differences in expression between cirrhosis and normal livers (adjusted *P* \> 0.05 or FC \< 1.5).

![Heatmap of modular gene expression in normal, cirrhotic, and HCC livers. GSE89377 dataset contained 13, 12, and 35 normal, cirrhosis, and HCC subjects, respectively. Modular gene expression in GSE89377 was normalized by antilog-transformed RMA value. Heatmap of modular gene expression was generated by MeV software. Differential gene expression analysis between the two groups was performed using GEO2R. FC represents fold-change. Red indicates high expression and blue signifies low expression.](fgene-10-00305-g005){#F5}

Association of Top Modular Gene Signatures With HCC Onset, Progression, and Prognosis
-------------------------------------------------------------------------------------

We next focused on the top modular gene signatures because their expression was highly dysregulated in the HCC tissues of all four datasets considered in this study. In total, five modular genes including TOP2A, CDC20, PRC1, CCNB2, and NUSAP1 satisfied the criterion stated in Section "Materials and Methods," therefore they were considered as the top modular gene signatures.

The liver cancer datasets in TCGA database contained 50 normal subjects, 54 HCC subjects with grade I, 173 HCC subjects with grade II, 118 HCC subjects with grade III, and 12 HCC subjects with grade IV. As shown in [Figure 6A](#F6){ref-type="fig"}, all the top modular gene signatures were significantly upregulated in each HCC grade group, compared with the normal group (*P* \< 0.05), and the expression of all genes increased in a stepwise manner with the HCC progress, suggesting a close relationship between the five genes and HCC onset and progression.

![Association of TOP2A, CDC20, PRC1, CCNB2, and NUSAP1 expression with HCC progression and prognosis. **(A)** Validation of the association between the expression levels of TOP2A, CDC20, PRC1, CCNB2, and NUSAP1 and the pathological stages of HCC (based on TCGA data in UALCAN web-tool). **(B)** Kaplan--Meier analysis of overall survival in HCC patients in TCGA liver cancer dataset based on TOP2A, CDC20, PRC1, CCNB2, and NUSAP1 expression.](fgene-10-00305-g006){#F6}

To investigate if the top modular gene signatures affected overall survival in patients with HCC, we performed a survival prediction by Kaplan--Meier curve analysis embedded in UALCAN web-tool. As shown in [Figure 6B](#F6){ref-type="fig"}, high expression of TOP2A, CDC20, and CCNB2 protein was significantly associated with poor survival time in HCC patients (*P* \< 0.01). Although lower expression of PRC1 and NUSAP1 tended to be associated with better outcome in HCC patients, significant differences were not achieved (*P* \> 0.05).

Protein Expression and Distribution of TOP2A, CDC20, PRC1, CCNB2, and NUSAP1 in HCC Livers
------------------------------------------------------------------------------------------

In the HPA database, we were able to find normal and HCC sections from several patients with staining for the top modular proteins. Antibodies used in the HPA database were: TOP2A (HPA006458), CDC20 (CAB004525), PRC1 (HPA034521), CCNB2 (CAB009575), and NUSAP1 (HPA043904).

Immunohistochemistry for the five members in the HPA database showed that TOP2A and NUSAP1 highly expressed in HCC cell nuclei but almost undetectable in normal tissue, whereas PRC1 highly expressed in HCC cytoplasm and plasma membrane but undetectable in normal liver tissue. Although CDC20 and CCNB2 exhibited higher rate of expression in HCC cytoplasm and plasma membrane, their abundance was very low ([Figure 7](#F7){ref-type="fig"}). Hence, TOP2A, PRC1, and NUSAP1 have the potential to be liver biopsy-based markers for screening HCC high-risk patients with cirrhosis.

![TOP2A, CDC20, PRC1, CCNB2, and NUSAP1 proteins expression in normal and HCC tissues from the HPA database. Selected immunohistochemistry images of proteins (TOP2A, PRC1, and NUSAP1) detected in HPA database that showed almost negative staining in normal tissue but rather high expression in HCC tissue. Magnification, 100×. HCC, hepatocellular carcinoma; HPA, Human Protein Atlas.](fgene-10-00305-g007){#F7}

Discussion
==========

Our current study systematically integrated four independent microarray datasets that contains cirrhosis and HCC tissues. By performing a series of bioinformatics analyses, we found a highly connected module covering 65 HCC risky genes, which could robustly distinguish cirrhosis from HCC; the top modular genes were highly associated with HCC onset and development and prognosis.

The module identified in the present study was highly connected; by functional enrichment analysis, the modular genes were found to be involved in several KEGG pathways. Mismatch repair pathway usually corrects insertion/deletion loops and base--base mismatches generated during DNA replication and recombination; base excision repair pathway is the main repair mechanism for DNA damage; the two pathways together with cell cycle and DNA replication pathways are the foundational mechanisms determining cell fate associated with carcinogenesis ([@B30]; [@B6]; [@B34]; [@B29]). P53 signaling pathway inhibition has been widely reported to be required for liver cancer initiation ([@B7]; [@B13]). Cellular senescence, a process of cell proliferation arrest in response to multifarious stimuli, which can modify the microenvironment of tissues, has been reported to be closely associated with cancer onset of multiple tissues including liver ([@B20]). Since the increase of senescent cells, it is likely that the preneoplastic setting of the cirrhotic background may provide a conducive environment for cellular transformation, which should be further investigated. Although human T-cell leukemia virus 1 infection pathway has not been reported to be linked to HCC, but the upregulation of modular genes involved in this pathway such as CDC20, MAD2L1, and PTTG1 have been confirmed to promote HCC development and progression ([@B11]; [@B22]; [@B24]). Except the pathways mentioned above, "oocyte meiosis" and "progesterone-mediated oocyte maturation" are two main KEGG pathways which the identified modular gene were enriched in. Oocyte meiosis and progesterone-mediated oocyte maturation pathways have also been found to be associated with HCC by integrated analysis of microarray studies ([@B23]; [@B48]). However, the causal association between oocyte meiosis and HCC onset should be investigated in further study.

The top modular genes, TOP2A, CDC20, PRC1, CCNB2, and NUSAP1, were highly associated with HCC onset and development; high expression of TOP2A, CDC20, or CCNB2 was correlated with poor survival time in TCGA liver cancer patients, implying their potential as biopsy-based prognostic markers. Consistent with our findings in the HPA database, previous studies have also found that TOP2A ([@B35]; [@B1]; [@B54]; [@B25]; [@B50]; [@B59]), CCNB2 ([@B27]; [@B59]), CDC20 ([@B22]; [@B19]; [@B23]; [@B55]; [@B15]), PRC1 ([@B10]; [@B49]; [@B28]), and NUSAP1 ([@B58]; [@B37]; [@B59]) are overexpressed in HCC but are almost undetectable in non-tumorous livers. TOP2A has been previously confirmed to correlate with advance histological grading, microvascular invasion, early age onset, shorter patient survival, and chemoresistance of HCC ([@B52]). High expression of CDC20 in HCC patients is associated with shorter overall survival ([@B15]); silencing of CDC20 expression significantly inhibits HCC cell proliferation and tumor growth ([@B22], [@B26]). PRC1 in HCC tissue is regulated by Wnt3a signaling, exerting an oncogenic effect by promoting cancer proliferation, stemness, metastasis, and tumorigenesis; high expression of PRC1 was associated with early HCC recurrence and poor patient outcome ([@B10]; [@B49]). Finally, NUSAP1 expression in the surgical margins of HCC is closely correlated to early postoperative recurrence and could serve as an indicator for predicting early recurrence of HCC ([@B58]).

Despite studies devoted to decoding the process of cirrhosis development to HCC have been extensively reported, integrated studies based on multiple datasets are rare. Prior to this current work, only one study had been reported by [@B18] who performed a weighted gene co-expression network analysis based on five independent gene expression profiles and identified six modules contributing to HCC progression. They found hub genes in the identified modules were mainly cytokines, such as chemokine (C-C motif) ligand 22 and interleukin-19 ([@B18]). However, our study found only one highly connected module that closely involved in the canonical carcinogenesis-associated pathways. The following reasons may at least partly explain such difference. First, cirrhotic tissues in each microarray dataset included in our study were benign tissues only and not mixture of benign and para-carcinoma tissues. Second, the microarray profiles in our study were generated by more than one platform and etiologies covered HBV, HCV, HDV, alcohol, and others. In order to obtain more reliable results, gene expression datasets from different microarray platforms and etiologies were considered; the overlapped DEGs were retained for further analysis; datasets were separated into training and test datasets, and the ability of the identified functional module distinguishing cirrhosis from HCC was validated in the test dataset; resampling and repeated evaluations obtained robust results; moreover, the associations between the expression of the top modular genes and HCC progression and prognosis were determined in other liver cancer datasets.

Conclusion
==========

Our present study systematically integrated multiple microarray gene expression profiles and found a module associated with liver carcinogenesis on a cirrhotic background that could robustly discriminate cirrhosis from HCC. The expression of top modular genes was closely associated with HCC onset, development, and prognosis. Our work may provide a deeper understanding of molecular mechanisms in HCC onset from cirrhosis and offer new insights for screening and surveillance of high-risk patients with cirrhosis during anti-viral therapy.
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DEGs

:   differentially expressed genes

EMT

:   epithelial-to-mesenchymal transition

FC

:   fold-change

FDR

:   false discovery rate

HPA

:   Human Protein Atlas

GEO

:   Gene Expression Omnibus

HCC

:   hepatocellular carcinoma

KEGG

:   Kyoto Encyclopedia of Genes and Genomes

MAPK

:   mitogen-activated protein kinase

MCODE

:   molecular complex detection

PCA

:   principal component analysis

RMA

:   robust multichip average

STRING

:   Search Tool for the Retrieval of Interacting Genes

TCGA

:   the Cancer Genome Atlas

TPM

:   transcripts per million.
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